p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme

被引：0
|
作者：
Jiao Meng
Wei Qian
Zhenkun Yang
Lingli Gong
Daxing Xu
Hongbo Huang
Xinyi Jiang
Zhening Pu
Ying Yin
Jian Zou
机构：
[1] The Affiliated Wuxi People’s Hospital of Nanjing Medical University,Department of Laboratory Medicine, Wuxi People’s Hospital, Wuxi Medical Center
[2] Nanjing Medical University,Center of Clinical Research, Wuxi People’s Hospital, Wuxi Medical Center
[3] The Affiliated Wuxi People’s Hospital of Nanjing Medical University,NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine
[4] Nanjing Medical University, Department of Clinical Laborator
[5] Jiangsu Institute of Nuclear Medicine,undefined
[6] Kunshan Hospital of Traditional Chinese Medicine,undefined
[7] Kunshan,undefined
来源：
BMC Cancer | / 24卷
关键词：
E2F7; p53; Chemoresistance; Temozolomide; Glioblastoma multiforme;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Abnormal p53 expression and radiographically assessed radiation response in glioblastoma multiforme (GM).
    Simmons, ML
    Barker, FG
    Prados, MD
    Chang, SM
    Lamborn, KR
    Wara, WM
    Sneed, PK
    Larson, DA
    Bollen, AW
    Davis, RL
    Wilson, CB
    Berger, MS
    Chen, P
    Aldape, K
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1998, 57 (05): : 470 - 470
  • [42] JNK2 downregulation promotes tumorigenesis and chemoresistance by decreasing p53 stability in bladder cancer
    Pan, Chun-Wu
    Liu, Hailong
    Zhao, Yu
    Qian, Chenchen
    Wang, Liguo
    Qi, Jun
    ONCOTARGET, 2016, 7 (23) : 35119 - 35131
  • [43] p53 and E2f: partners in life and death
    Shirley Polager
    Doron Ginsberg
    Nature Reviews Cancer, 2009, 9 : 738 - 748
  • [44] p53 and E2f: partners in life and death
    Polager, Shirley
    Ginsberg, Doron
    NATURE REVIEWS CANCER, 2009, 9 (10) : 738 - 748
  • [45] Age-related expression of p53, Mdm2, EGFR and Msh2 in glioblastoma multiforme
    Stark, AM
    Hugo, HH
    Witzel, P
    Mihajlovic, Z
    Mehdorn, HM
    ZENTRALBLATT FUR NEUROCHIRURGIE, 2003, 64 (01): : 30 - 36
  • [46] p53, mdm2, EGFR, and msh2 expression in paired initial and recurrent glioblastoma multiforme
    Stark, AM
    Witzel, P
    Strege, RJ
    Hugo, HH
    Mehdorn, HM
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (06): : 779 - 783
  • [47] Dexmedetomidine promotes ferroptotic cell death in gastric cancer via hsa_circ_0008035/miR-302a/E2F7 axis
    Gao, Xiang
    Wang, Xiao-Liang
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2023, 39 (04): : 390 - 403
  • [48] Prolonged temozolomide for treatment of glioblastoma: preliminary clinical results and prognostic value of p53 overexpression
    Nadia Malkoun
    Cyrus Chargari
    Fabien Forest
    Marie-Jeannette Fotso
    Lysian Cartier
    Pierre Auberdiac
    Julie Thorin
    Cécile Pacaut
    Michel Peoc’h
    Christophe Nuti
    Thierry Schmitt
    Nicolas Magné
    Journal of Neuro-Oncology, 2012, 106 : 127 - 133
  • [49] Prolonged temozolomide for treatment of glioblastoma: preliminary clinical results and prognostic value of p53 overexpression
    Malkoun, Nadia
    Chargari, Cyrus
    Forest, Fabien
    Fotso, Marie-Jeannette
    Cartier, Lysian
    Auberdiac, Pierre
    Thorin, Julie
    Pacaut, Cecile
    Peoc'h, Michel
    Nuti, Christophe
    Schmitt, Thierry
    Magne, Nicolas
    JOURNAL OF NEURO-ONCOLOGY, 2012, 106 (01) : 127 - 133
  • [50] The c-MYC-WDR43 signalling axis promotes chemoresistance and tumour growth in colorectal cancer by inhibiting p53 activity
    Di, Yuqin
    Jing, Xiaoqian
    Hu, Kunhua
    Wen, Xiangqiong
    Ye, Lvlan
    Zhang, Xiang
    Qin, Jiale
    Ye, Jinning
    Lin, Run
    Wang, Ziyang
    He, Weiling
    DRUG RESISTANCE UPDATES, 2023, 66
12345